WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 9301 Infant (under 12 months) mortality rate: 382
GDP / capita (US$): 2'5911 Child (under 5 years) mortality rate: 542

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 50'757  49'253  47'783  46'355  44'973  34'021  25'485  18'687 
Births 1'964  1'931  1'898  1'866  1'832  1'423  1'128  875 
Surviving infants 1'873  1'838  1'804  1'769  1'733  1'302  1'013  783 
Pop. less than 5 years 8'820  8'657  8'487  8'291  8'053  5'903  4'641  3'542 
Pop. less than 15 years 22'732  22'091  21'451  20'810  20'166  15'233  11'721  8'697 
Female 15-49 years 11'557  11'196  10'850  10'522  10'215  7'802  5'777  4'211 

Number of reported case

(Click for retrospective incidence data for United Republic of Tanzania)
Diphtheria
Japanese encephalitis
Measles 88  185  1'668  1'622  167  14'649  14'920  63'100 
Mumps
Pertussis 243  2'788 
Polio* 91 
Rubella 529  116  55  18  121 
Rubella (CRS)
Tetanus (neonatal) 48  28  652 
Tetanus (total)** 28 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for United Republic of Tanzania)
Vaccine year result method % card seen                                                
BCG 2010  99  EPI   76  99  99*  99*  99*  99  86  85  72 
DTP1 2010  97  EPI   76  99  99*  99  98  98 
DTP3 2010  95  EPI   76  97  91  92  92  91  79  78  59 
DTP4         
IPV1         
HepB_BD         
HepB3 2010  95  EPI   76  97  91  92  92  91 
Hib3 2010  95  EPI   76  97  91  92  92  91 
JapEnc         
MCV1          99  99  97  95  92  78  80  46 
MCV2          29 
PCV1          99  94 
PCV3          93  80 
Pol3 2010  92  EPI   76  97  91  90  91  94  64  78  57 
Rota1          99  95 
Rota_last          97  85 
Rubella1          99 
TT2plus 2010  66  EPI   76  93  79  79  76  73  77  65  41 
PAB         
VAD1          81  87 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for United Republic of Tanzania)
BCG 99  99  99  99  99  86  85  72 
DTP1 99  99  99  96  98  92  92  81 
DTP3 97  91  92  90  91  79  78  59 
HepB3 97  91  92  90  91 
HepB_BD
Hib3 97  91  92  90  91 
MCV1 99  99  97  93  92  78  80  46 
MCV2 29 
PAB 88  88  88  88  83  79  77  37 
PCV3 93  80 
Pol3 97  91  90  88  94  64  78  57 
Rota_last 97  85 
YFV

Number of districts in the country 173  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 72
From 80 to 89% 17
From 50 to 79% 11
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 9 years (2 doses); No From April 2015
HepB 1st contact; +1, +1 months; Yes at risk health workers
IPV 14 weeks; Yes From October 2015
MR 9, 18 months; Yes
Measles 9, 18 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes CBAW and pregnant women

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2015  2010-2015  2010-2014  2010-2015  2010 - 2014  2010 -2014  2006 - 2010 
Nº of districts with microplans that include activities to raise immunization coverage number 173  145  129  129  61  61  20 

System performance

Total Nº districts in country number 173  145  129  129  129  129  129 
Nº districts with DTP3 coverage >=80% number 154  115  112  106  102  91  87 
% of districts with DTP3 coverage >=80% From 0 to 100% 89  79  87  82  79  71  67 
Nº districts with measles (MCV1) coverage >=95% number 114  89  71  52  48  46  36 
% of districts with MCV1 coverage >=95% From 0 to 100% 66  61  55  40  37  36  28 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 21  22      21  59 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  Yes  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.